GGrantIndex
← Leaderboards

Stuart N. Isaacs

University Of Pennsylvania

Google Scholar ↗PubMed ↗ORCID ↗
$9,020,266
Attributed
$9,020,266
Total exposure
10
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.6M · FY2005–21
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$9,020,266 · 10

By mechanism

U01$5,271,206 · 3
R01$1,765,294 · 1
U54$762,611 · 2
G20$495,490 · 1
R21$452,422 · 1
R29$270,243 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Vaccinia Virus”

Research focus

Vaccinia VirusProteinsPoxviridaeLaboratory MouseMonkeypoxViral ProteinsVaccinesCollaborationsVirus ProteinBaseSmallpox VaccineProtein Structure FunctionResponseVirusImmune ResponseVaccine DevelopmentResearch PersonnelComplementEnvironmentNonhuman PrimateSmallpoxOrthopoxvirusPlayBioterrorism

Grant awards (28)

XXIII International Poxvirus, Asfarvirus, and Iridovirus Conference$3,000
R13 · FY2021 · AI · contact PI
Enhancement and Expansion: Penn Neurophysiology and Behavior Testing Facility$495,490
G20 · FY2016 · OD · contact PI
Novel approaches to propagate molluscum contagiosum virus in cell culture$246,211
R21 · FY2016 · AI · contact PI
Novel approaches to propagate molluscum contagiosum virus in cell culture$206,211
R21 · FY2015 · AI · contact PI
Optimizing the formulation of a protein based smallpox vaccine$594,154
U01 · FY2012 · AI · contact PI
Optimizing the formulation of a protein based smallpox vaccine$490,719
U01 · FY2011 · AI · contact PI
Optimizing the formulation of a protein based smallpox vaccine$357,262
U01 · FY2010 · AI · contact PI
Optimizing the formulation of a protein based smallpox vaccine$567,762
U01 · FY2009 · AI · contact PI
Smallpox vaccine and vaccinia complement control protein$324,409
U01 · FY2009 · AI · contact PI
Smallpox vaccine and vaccinia complement control protein$25,000
U01 · FY2009 · AI · contact PI
Poxvirus$691,663
U54 · FY2008 · AI · contact PI
Optimizing the formulation of a protein based smallpox vaccine$538,930
U01 · FY2008 · AI · contact PI
Smallpox vaccine and vaccinia complement control protein$314,962
U01 · FY2008 · AI · contact PI
New Opportunities - Mechanisms of Early Vaccinia Viral Morphogensis$70,948
U54 · FY2008 · AI · contact PI
Smallpox vaccine and vaccinia complement control protein$311,712
U01 · FY2007 · AI · contact PI
Smallpox vaccine and vaccinia complement control protein$310,841
U01 · FY2006 · AI · contact PI
VACCINIA B5R PROTEIN IN SPREAD IMMUNE EVASION, VACCINES$356,625
R01 · FY2005 · AI
Smallpox vaccine and vaccinia complement control protein$333,300
U01 · FY2005 · AI
VACCINIA B5R PROTEIN IN SPREAD IMMUNE EVASION, VACCINES$356,625
R01 · FY2004 · AI
VACCINIA B5R PROTEIN IN SPREAD IMMUNE EVASION, VACCINES$356,625
R01 · FY2003 · AI
POXVIRUS SCR-CONTAINING PROTEINS AS THERAPEUTIC TARGETS$294,035
U01 · FY2003 · AI
VACCINIA B5R PROTEIN IN SPREAD IMMUNE EVASION, VACCINES$356,625
R01 · FY2002 · AI
POXVIRUS SCR-CONTAINING PROTEINS AS THERAPEUTIC TARGETS$268,453
U01 · FY2002 · AI
VACCINIA B5R PROTEIN IN SPREAD IMMUNE EVASION, VACCINES$338,794
R01 · FY2001 · AI
POXVIRUS SCR-CONTAINING PROTEINS AS THERAPEUTIC TARGETS$279,635
U01 · FY2001 · AI
VACCINIA B5R PROTEIN IN DISSEMINATION AND IMMUNE EVASION$136,745
R29 · FY2001 · AI
POXVIRUS SCR-CONTAINING PROTEINS AS THERAPEUTIC TARGETS$260,032
U01 · FY2000 · AI
VACCINIA B5R PROTEIN IN DISSEMINATION AND IMMUNE EVASION$133,498
R29 · FY2000 · AI